The overall theme of the Program project outlined in this application is the genetics, cytokine regulation and inflammatory cell migration into rheumatoid synovium of an autoimmune arthritis, induced by systemic immunization of mice with cartilage proteoglycan (aggrecan). This proteoglycan (aggrecan)-induced arthritis (PGIA) shows many similarities to human rheumatoid arthritis (RA) as indicated by clinical assessments such as radiographic analyses, scintigraphic bone scans and various functional tests, and by histopathologic studies of diarthrodial joints. The development, and then the progressivity, of this RA-like disease is based upon autoimmune reactions which develop against the mouse (self) cartilage proteoglycan. Arthritis develop only in genetically susceptible BALB/c mice or their F2 hybrids. It is accompanied with inflammatory cell migration into the joint, mediated by Th1 type cytokines. We combined three research projects in one program to utilize a very unique condition of accumulated information and experience of investigators. Project 1 will identify non-MHC-linked loci int he mouse genome which harbor genes responsible for proteoglycan arthritis, and then to identify these genes by positional cloning. Project 2 will evaluate the function and balance of Th1 and Th2 cytokines, manipulate the Th1 cytokine dominance in pre-arthritic stage of the disease and explore the mechanisms as how the anti-inflammatory cytokines suppress inflammation in synovium. In addition, this project will perform preventive studies in SCID mice using human synovium and anti- inflammatory cytokines. Gene therapeutic approaches for delivery of Th2 cytokines in a site-specific fashion. Project 3 will study the function of CD44 in inflammatory cell migration and the different aspects of anti-CD44 treatment, and what the conditions of receptors of receptor shedding are in vitro and in vivo. This project will also utilize human synovium (normal or arthritic) in SCID mice to delineate how CD44 expression might be controlled by intracellular events (signal transduction). Each of the projects are highly integrated with each other and centered around a unique theme and supported by two Cores.

Agency
National Institute of Health (NIH)
Institute
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
Type
Research Program Projects (P01)
Project #
5P01AR045652-02
Application #
6164032
Study Section
Special Emphasis Panel (ZAR1-AAA-C (O3))
Program Officer
Gretz, Elizabeth
Project Start
1999-03-01
Project End
2004-02-29
Budget Start
2000-03-01
Budget End
2001-02-28
Support Year
2
Fiscal Year
2000
Total Cost
$944,283
Indirect Cost
Name
Rush University Medical Center
Department
Type
DUNS #
City
Chicago
State
IL
Country
United States
Zip Code
60612
Kugyelka, Reka; Kohl, Zoltan; Olasz, Katalin et al. (2016) Enigma of IL-17 and Th17 Cells in Rheumatoid Arthritis and in Autoimmune Animal Models of Arthritis. Mediators Inflamm 2016:6145810
Hanyecz, A; Olasz, K; Tarjanyi, O et al. (2014) Proteoglycan aggrecan conducting T cell activation and apoptosis in a murine model of rheumatoid arthritis. Biomed Res Int 2014:942148
Kobezda, Tamás; Ghassemi-Nejad, Sheida; Mikecz, Katalin et al. (2014) Of mice and men: how animal models advance our understanding of T-cell function in RA. Nat Rev Rheumatol 10:160-70
Kis-Toth, Katalin; Radacs, Marianna; Olasz, Katalin et al. (2012) Arthritogenic T cells drive the recovery of autoantibody-producing B cell homeostasis and the adoptive transfer of arthritis in SCID mice. Int Immunol 24:507-17
Besenyei, Timea; Kadar, Andras; Tryniszewska, Beata et al. (2012) Non-MHC risk alleles in rheumatoid arthritis and in the syntenic chromosome regions of corresponding animal models. Clin Dev Immunol 2012:284751
Nagyeri, Gyorgy; Radacs, Marianna; Ghassemi-Nejad, Sheida et al. (2011) TSG-6 protein, a negative regulator of inflammatory arthritis, forms a ternary complex with murine mast cell tryptases and heparin. J Biol Chem 286:23559-69
Glant, Tibor T; Radacs, Marianna; Nagyeri, Gyorgy et al. (2011) Proteoglycan-induced arthritis and recombinant human proteoglycan aggrecan G1 domain-induced arthritis in BALB/c mice resembling two subtypes of rheumatoid arthritis. Arthritis Rheum 63:1312-21
Doodes, Paul D; Cao, Yanxia; Hamel, Keith M et al. (2010) IFN-gamma regulates the requirement for IL-17 in proteoglycan-induced arthritis. J Immunol 184:1552-9
Wiranowska, Marzenna; Ladd, Sharron; Moscinski, Lynn C et al. (2010) Modulation of hyaluronan production by CD44 positive glioma cells. Int J Cancer 127:532-42
Angyal, Adrienn; Egelston, Colt; Kobezda, Tamas et al. (2010) Development of proteoglycan-induced arthritis depends on T cell-supported autoantibody production, but does not involve significant influx of T cells into the joints. Arthritis Res Ther 12:R44

Showing the most recent 10 out of 66 publications